Jonas Salk's work was not without challenges. He faced skepticism and criticism from parts of the scientific community, who were more supportive of the "live-virus" approach. Additionally, the mass production and distribution of the vaccine required overcoming significant logistical challenges. Despite these hurdles, Salk's determination and innovative methods led to a breakthrough that altered the course of public health.
